Acetylsalicylic acid Withdrawn Phase 3 Trials for Peripheral Arterial Disease (PAD) / Endovascular Procedures Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02433587Short vs Long Duration Dual Antiplatelet Therapy in Patients Undergoing Lower Extremity Endovascular Revascularization